Literature DB >> 9674173

[Von Willebrand factor and pulmonary endothelial dysfunction. Prognostic implications].

A A Lopes1, N Y Maeda, S P Bydlowski.   

Abstract

PURPOSE: To analyze quantitative and structural changes in circulating von Willebrand factor (vWF) in 40 precapillary pulmonary hypertensive patients, as an attempt to identify possible correlations between endothelial cell dysfunction and patient short-term (one year) survival.
METHODS: Plasma antigenic activity of vWF (vWF:Ag) was analyzed by immunoelectrophoresis. The relative concentration of vWF low molecular weight multimers (LMWM%) and the composition of vWF subunit were determined by densitometric analysis of Western blots.
RESULTS: vWF:Ag was importantly increased in patients in comparison with normals (p < 0.001). Patients also had increased LMWM% (p < 0.001) and increased degradation of vWF main subunit (p < 0.05). At the beginning of the study, nonsurvivors (N = 11) had higher vWF:Ag (p < 0.001) and LMWM% (p < 0.005) values in comparison with survivors. LMWM% was selected by logistic regression analysis as a predictor of death during the first year of follow-up (p < 0.05).
CONCLUSION: Marked changes in circulating vWF likely reflect extensive pulmonary vascular endothelial cell dysfunction and are associated with poor short-term prognosis in pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674173     DOI: 10.1590/s0066-782x1998000300001

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  1 in total

Review 1.  Von Willebrand Disease Lab Diagnosis.

Authors:  Francine Charan de Faria; Railson Henneberg; Aguinaldo José do Nascimento; Karen Sumire Kubo; Henrique Ravanhol Frigeri; Paulo Henrique da Silva
Journal:  Indian J Hematol Blood Transfus       Date:  2015-12-12       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.